NHI · National Health Investors Inc · Analyst Estimates
$62.95
-1.60 (-2.48%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”View the 10-Q filed Aug 10, 2026
Market Cap
$3.09B
Shares
49.11M
Volume · Nov 13
493.71K
Avg daily vol (3M)
339.91K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for National Health Investors Inc across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-14 10:58 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
3.38
|
4.02
|
4.66
|
2
|
4.06
|
4.06
|
3.89
|
4.19
|
0
|
0
|
0
|
1
|
|
Revenue
USD
Publication date not stated |
445.86M
|
447.32M
|
448.30M
|
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
3.03
|
3.03
|
3.03
|
1
|
3.45
|
3.35
|
3.25
|
3.31
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
467.79M
|
485.26M
|
514.46M
|
6
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.68
|
1.51
|
1.93
|
3
|
1.51
|
1.32
|
1.54
|
1.96
|
0
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
111.12M
|
112.64M
|
113.60M
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.73
|
0.73
|
0.73
|
1
|
0.75
|
0.75
|
0.75
|
0.75
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
109.64M
|
116.15M
|
123.96M
|
5
|
— | — | — | — | — | — | — | — |
Key facts
CIK
877860
CUSIP
63633D104
13F (30d)
278 filings
241 filers
Visit website
Investor relations